Edition:
United Kingdom

People: Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

5.42CAD
16 Aug 2019
Change (% chg)

$0.01 (+0.18%)
Prev Close
$5.41
Open
$5.43
Day's High
$5.58
Day's Low
$5.29
Volume
40,290
Avg. Vol
108,805
52-wk High
$11.45
52-wk Low
$4.86

Marsolais, Christian 

Dr. Christian Marsolais, Ph.D., is Senior Vice President - Scientific Affairs and Alliances of Theratechnologies, Inc. Dr. Marsolais has over 15 years of experience in clinical research for large pharmaceutical companies, such as Sandoz Canada Inc. and BioChem Therapeutics Inc. Before joining us in 2007, Dr. Marsolais held various positions at Pfizer Global Pharmaceuticals, where he was appointed Director of Medical Affairs, Therapeutic Areas, in 2004. In this position, Dr. Marsolais was responsible for the clinical program and scientific initiatives development, as well as the integration of the Scientific Affairs and Clinical Research for the oncology and HIV Franchise. Dr. Marsolais holds a Ph.D. in Biochemistry from the Université de Montréal.

Basic Compensation

Total Annual Compensation, CAD 320,000
Restricted Stock Award, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 12,135
Fiscal Year Total, CAD 332,135

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --